The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
09 2019
Historique:
received: 15 01 2019
pubmed: 28 5 2019
medline: 18 11 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

Atrial tachycardias (ATs) are often seen in the context of atrial fibrillation (AF) ablation. To evaluate the role of the Marshall bundle (MB) network in left atrial (LA) ATs using high-density 3-dimensional mapping. A total of 199 ATs were mapped in 140 patients (112 male, mean age: 61.8 years); 133 (66.8%) were macroreentrant and 66 (33.2%) were scar-related reentry circuits. MB-dependent ATs were suggested by activation mapping analysis and confirmed with entrainment along the circuit. The MB network participated in 60 (30.2%) reentrant ATs: 31 perimitral ATs (PMATs) and 29 localized reentry circuits. Of 60 MB-related ATs, 49 (81.6%) terminated with radiofrequency (RF) ablation: 44 (73.3%) at the MB-LA junction and 5 (8.3%) at the MB-coronary sinus (CS) junction, while 9 (15%) terminated after 2.5-5 cc of ethanol infusion inside the vein of Marshall (VOM). Of the 31 PMATs, 17 (54.8%) terminated at the MB-LA junction, 5 (16.1%) at the MB-CS junction, and 7 (22.6%) with ethanol infusion. Of the 29 localized reentry circuits using the MB, 27 (93.1%) terminated at the MB-LA junction, none at the MB-CS junction, and 2 (6.9%) after ethanol infusion. Recurrences were mostly observed after RF ablation (18 of 37 patients, 49%) compared to ethanol infusion (1 of 9 patients, 11%) (P = .06). MB reentrant ATs accounted for up to 30.2% of the left ATs after AF ablation. Ablation of the MB-LA or CS-MB connections or ethanol infusion inside the VOM is required to treat these arrhythmias.

Sections du résumé

BACKGROUND
Atrial tachycardias (ATs) are often seen in the context of atrial fibrillation (AF) ablation.
OBJECTIVES
To evaluate the role of the Marshall bundle (MB) network in left atrial (LA) ATs using high-density 3-dimensional mapping.
METHODS
A total of 199 ATs were mapped in 140 patients (112 male, mean age: 61.8 years); 133 (66.8%) were macroreentrant and 66 (33.2%) were scar-related reentry circuits. MB-dependent ATs were suggested by activation mapping analysis and confirmed with entrainment along the circuit.
RESULTS
The MB network participated in 60 (30.2%) reentrant ATs: 31 perimitral ATs (PMATs) and 29 localized reentry circuits. Of 60 MB-related ATs, 49 (81.6%) terminated with radiofrequency (RF) ablation: 44 (73.3%) at the MB-LA junction and 5 (8.3%) at the MB-coronary sinus (CS) junction, while 9 (15%) terminated after 2.5-5 cc of ethanol infusion inside the vein of Marshall (VOM). Of the 31 PMATs, 17 (54.8%) terminated at the MB-LA junction, 5 (16.1%) at the MB-CS junction, and 7 (22.6%) with ethanol infusion. Of the 29 localized reentry circuits using the MB, 27 (93.1%) terminated at the MB-LA junction, none at the MB-CS junction, and 2 (6.9%) after ethanol infusion. Recurrences were mostly observed after RF ablation (18 of 37 patients, 49%) compared to ethanol infusion (1 of 9 patients, 11%) (P = .06).
CONCLUSIONS
MB reentrant ATs accounted for up to 30.2% of the left ATs after AF ablation. Ablation of the MB-LA or CS-MB connections or ethanol infusion inside the VOM is required to treat these arrhythmias.

Identifiants

pubmed: 31125669
pii: S1547-5271(19)30460-6
doi: 10.1016/j.hrthm.2019.05.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1341-1347

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Konstantinos Vlachos (K)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Arnaud Denis (A)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Masateru Takigawa (M)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Takeshi Kitamura (T)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Claire A Martin (CA)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France; Royal Papworth Hospital, Cambridge, United Kingdom.

Antonio Frontera (A)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Ruairidh Martin (R)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

George Bazoukis (G)

Second Department of Cardiology, Evangelismos General Hospital, Athens, Greece.

Felix Bourier (F)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Ghassen Cheniti (G)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Josselin Duchateau (J)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Nathaniel Thompson (N)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Gregoire Massoullie (G)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Anna Lam (A)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Michael Wolf (M)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

William Escande (W)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Nicolas Klotz (N)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Thomas Pambrun (T)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Frederic Sacher (F)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Meleze Hocini (M)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Michel Haissaguerre (M)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Pierre Jais (P)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France.

Nicolas Derval (N)

Hôpital Cardiologique du Haut-Lévèque, CHU Bordeaux, LIRYC, L'institut de Rythmologie et Modélisation cardiaque, Université de Bordeaux, Bordeaux, France. Electronic address: dervalnicolas@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH